Literature DB >> 15530367

Crystal structures of Ral-GppNHp and Ral-GDP reveal two binding sites that are also present in Ras and Rap.

Nathan I Nicely1, Justin Kosak, Vesna de Serrano, Carla Mattos.   

Abstract

RalA is a GTPase with effectors such as Sec5 and Exo84 in the exocyst complex and RalBP1, a GAP for Rho proteins. We report the crystal structures of Ral-GppNHp and Ral-GDP. Disordered switch I and switch II, located away from crystal contacts, are observed in one of the molecules in the asymmetric unit of the Ral-GppNHp structure. In the other molecule in the asymmetric unit, a second Mg(2+) ion is bound to the GppNHp gamma-phosphate in an environment in which switch I is pulled away from the nucleotide and switch II is found in a tight beta turn. Clustering of conserved residues on the surface of Ral-GppNHp identifies two putative sites for protein-protein interaction. One site is adjacent to switch I. The other is modulated by switch II and is obstructed in Ral-GDP. The Ral structures are discussed in the context of the published structures of the Ral/Sec5 complex, Ras, and Rap.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530367     DOI: 10.1016/j.str.2004.08.011

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  18 in total

Review 1.  C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.

Authors:  Martin Vogelsgesang; Alexander Pautsch; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-05       Impact factor: 3.000

2.  The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response.

Authors:  Michal Simicek; Sam Lievens; Mathias Laga; Dmytro Guzenko; Vasily N Aushev; Peter Kalev; Maria Francesca Baietti; Sergei V Strelkov; Kris Gevaert; Jan Tavernier; Anna A Sablina
Journal:  Nat Cell Biol       Date:  2013-09-22       Impact factor: 28.824

3.  Critical roles of interactions among switch I-preceding residues and between switch II and its neighboring alpha-helix in conformational dynamics of the GTP-bound Ras family small GTPases.

Authors:  Kousuke Matsumoto; Fumi Shima; Shin Muraoka; Mitsugu Araki; Lizhi Hu; Yuichi Ijiri; Rina Hirai; Jingling Liao; Takashi Yoshioka; Takashi Kumasaka; Masaki Yamamoto; Atsuo Tamura; Tohru Kataoka
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

4.  Crystal structure of the C3bot-RalA complex reveals a novel type of action of a bacterial exoenzyme.

Authors:  Alexander Pautsch; Martin Vogelsgesang; Jens Tränkle; Christian Herrmann; Klaus Aktories
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

5.  Exo84 and Sec5 are competitive regulatory Sec6/8 effectors to the RalA GTPase.

Authors:  Rongsheng Jin; Jagath R Junutula; Hugo T Matern; Karen E Ervin; Richard H Scheller; Axel T Brunger
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

6.  Conformational resolution of nucleotide cycling and effector interactions for multiple small GTPases determined in parallel.

Authors:  Ryan C Killoran; Matthew J Smith
Journal:  J Biol Chem       Date:  2019-05-14       Impact factor: 5.157

7.  Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases.

Authors:  Khuchtumur Bum-Erdene; Degang Liu; Giovanni Gonzalez-Gutierrez; Mona K Ghozayel; David Xu; Samy O Meroueh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

Review 8.  Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame.

Authors:  Leanna R Gentry; Timothy D Martin; David J Reiner; Channing J Der
Journal:  Biochim Biophys Acta       Date:  2014-09-16

Review 9.  RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.

Authors:  Chao Yan; Dan Theodorescu
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

10.  The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.

Authors:  R Brynmor Fenwick; Louise J Campbell; Karthik Rajasekar; Sunil Prasannan; Daniel Nietlispach; Jacques Camonis; Darerca Owen; Helen R Mott
Journal:  Structure       Date:  2010-08-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.